Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Control Subjects”

1,388 trials

Showing 20 of 1,388 results

Early research (Phase 1)Study completedNCT05497297
What this trial is testing

Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Haisco Pharmaceutical Group Co., Ltd. 42
Large-scale testing (Phase 3)Study completedNCT03263715
What this trial is testing

Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)

Who this might be right for
Polymyalgia Rheumatica
Medical University of Vienna 39
Testing effectiveness (Phase 2)UnknownNCT04078555
What this trial is testing

Evaluate ENERGI-F703 GEL in Venous Leg Ulcer

Who this might be right for
Venous Leg Ulcer
Energenesis Biomedical Co., Ltd. 80
Large-scale testing (Phase 3)UnknownNCT05620355
What this trial is testing

Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.

Who this might be right for
Uterine FibroidsHeavy Menstrual Bleeding
Bio Genuine (Shanghai) Biotech Co., Ltd. 312
Testing effectiveness (Phase 2)Study completedNCT03381625
What this trial is testing

Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis

Who this might be right for
PsoriasisAtopic Dermatitis
BioMimetix JV, LLC 139
Early research (Phase 1)Study completedNCT00958503
What this trial is testing

Effect of Thiamphenicol on EAAT2 and Other Biomarkers From Nasal Biopsied Tissue

Who this might be right for
Healthy
Psyadon Pharma 30
Testing effectiveness (Phase 2)Study completedNCT00804908
What this trial is testing

A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma

Who this might be right for
MelanomaMetastatic MelanomaSkin Cancer
AbbVie (prior sponsor, Abbott) 346
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Testing effectiveness (Phase 2)Study completedNCT02688270
What this trial is testing

Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon Secondary to Connective Tissue Disease
Covis Pharma S.à.r.l. 65
Early research (Phase 1)Study completedNCT07200596
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects

Who this might be right for
Rheumatoid Arthritis (RA)
Guangdong Hengrui Pharmaceutical Co., Ltd 16
Not applicableLooking for participantsNCT06987370
What this trial is testing

SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue

Who this might be right for
Bone Metastases in Subjects With Advanced Cancer
Shandong Cancer Hospital and Institute 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07598383
What this trial is testing

A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD 120
Early research (Phase 1)Looking for participantsNCT05533372
What this trial is testing

MAD Study of IA-14069

Who this might be right for
HealthyRheumatoid Arthritis
ILAb Co., Ltd. 75
Testing effectiveness (Phase 2)Study completedNCT03680131
What this trial is testing

Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis

Who this might be right for
Allergic Contact Dermatitis
Edesa Biotech Inc. 211
Large-scale testing (Phase 3)WithdrawnNCT04666675
What this trial is testing

Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil

Who this might be right for
Atopic Dermatitis (AD)
AbbVie
Post-approval studies (Phase 4)Ended earlyNCT01619670
What this trial is testing

A Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects With Epidermolysis Bullosa

Who this might be right for
Epidermolysis BullosaWound Healing
University Hospital, Basel, Switzerland 3
Testing effectiveness (Phase 2)Study completedNCT04927975
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo

Who this might be right for
Non-Segmental Vitiligo
AbbVie 185
Testing effectiveness (Phase 2)Study completedNCT01616654
What this trial is testing

Dose Range Study of CD5789 in Acne Vulgaris

Who this might be right for
Acne Vulgaris
Galderma R&D 304
Testing effectiveness (Phase 2)Ended earlyNCT00458861
What this trial is testing

BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biogen 115
Testing effectiveness (Phase 2)Study completedNCT02525094
What this trial is testing

Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
MedImmune LLC 113
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation